Zhiyue Tom Hu

Zhiyue Tom Hu

Auto-generated profile, based on publicly available information

Zhiyue Tom Hu

Division of Biostatistics , University of California Berkeley, Berkeley, CA 94720

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 December 2020
Verified
Conference Paper
Open access
IAIlan Adler
Ilan Adler
ZHZhiyue T. Hu
Zhiyue T. Hu
TLTianyi Lin
Tianyi Lin
In this paper, we propose new proximal Newton-type methods for convex optimization problems in composite form. The applications include model predictive control (MPC) and embedded MPC. Our new methods are computationally attractive since they do not require evaluating the Hessian at each iteration while keeping fast convergence rate. More specifically, we prove the global convergence is guaranteed and the superlinear convergence is achieved in the vicinity of an optimal solution. We also develop several practical variants by incorporating quasi-Newton and inexact subproblem solving schemes and provide theoretical guarantee for them under certain conditions. Experimental results on real-world datasets demonstrate the effectiveness and efficiency of new methods.

1 May 2025 in Briefings in Bioinformatics
Verified
Journal Article
Open access
ZHZhiyue Tom Hu
Zhiyue Tom Hu
YYYaodong Yu
Yaodong Yu
RCRuoqiao Chen
Ruoqiao Chen
SYShan-Ju Yeh
Shan-Ju Yeh
BCBin Chen
Bin Chen
HHHaiyan Huang
Haiyan Huang
Pharmacogenomics studies are attracting an increasing amount of interest from researchers in precision medicine. The advances in high-throughput experiments and multiplexed approaches allow the large-scale quantification of drug sensitivities in molecularly characterized cancer cell lines (CCLs), resulting in a number of open drug sensitivity datasets for drug biomarker discovery. However, a significant inconsistency in drug sensitivity values among these datasets has been noted. Such inconsistency indicates the presence of substantial noise, subsequently hindering downstream analyses. To address the noise in drug sensitivity data, we introduce a robust and scalable deep learning framework, Residual Thresholded Deep Matrix Factorization (RT-DMF). This method takes a single drug sensitivity data matrix as its sole input and outputs a corrected and imputed matrix. Deep matrix factorization (DMF) excels at uncovering subtle patterns, due to its minimal reliance on data structure assumptions. This attribute significantly boosts DMF’s ability to identify complex hidden patterns among nuisance effects in the data, thereby facilitating the detection of signals that are therapeutically relevant. Furthermore, RT-DMF incorporates an iterative residual thresholding procedure, which plays a crucial role in retaining signals more likely to hold therapeutic importance. Validation using simulated datasets and real pharmacogenomics datasets demonstrates the effectiveness of our approach in correcting noise and imputing missing data in drug sensitivity datasets (open-source package available at https://github.com/tomwhoooo/rtdmf).